* If the product has intellectual property rights, a license granted is must or contact us.
Introduction of 10605-02-4 :
Palmatine chloride is an orally active and irreversible indoleamine 2,3-dioxygenase 1 (IDO-1) inhibitor. Palmatine chloride can ameliorate DSS-induced colitis by mitigating colonic injury, preventing gut microbiota dysbiosis, and regulating tryptophan catabolism. Palmatine has the potential for colitis treatment. In Vitro: Palmatine exhibits more potent IDO-1 inhibitory activity , which IC50 on rhIDO-1 is 157 μM, and on HEK 293-hIDO-1 is 3 μM. In Vivo: Palmatine (oral administration; 50 or 100 mg/kg, 7 days) has less distortion of epithelium, and fewer infiltrations of inflammatory cells, resulting in significantly lower histopathological scores, it also significantly suppresses the colonic MPO activity.